LFG
AZN icon

Larson Financial Group’s AstraZeneca AZN Stock Holding History

Larson Financial Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$257K Buy
1,354
+20
+1% +$3.76K 0.01% 753
2026
Q1 		$263K Sell
1,334
-145
-10% -$28K 0.01% 638
2025
Q4 		$272K Buy
1,479
+861
+139% +$151K 0.01% 628
2025
Q3 		$94.9K Buy
618
+473
+326% +$71.6K ﹤0.01% 927
2025
Q2 		$20.3K Sell
145
-48
-25% -$6.73K ﹤0.01% 1485
2025
Q1 		$28.4K Buy
193
+144
+294% +$20.8K ﹤0.01% 1230
2024
Q4 		$6.34K Sell
49
-14
-22% -$1.96K ﹤0.01% 1608
2024
Q3 		$9.79K Buy
63
+9
+17% +$1.45K ﹤0.01% 1485
2024
Q2 		$8.31K Buy
54
+40
+286% +$6.02K ﹤0.01% 1312
2024
Q1 		$1.8K Buy
14
+1
+8% +$132 ﹤0.01% 1374
2023
Q4 		$1.78K Sell
13
-37
-74% -$4.81K ﹤0.01% 1383
2023
Q3 		$6.8K Buy
50
+37
+285% +$5.05K ﹤0.01% 1102
2023
Q2 		$1.89K Sell
13
-128
-91% -$18.8K ﹤0.01% 1277
2023
Q1 		$19.6K Buy
141
+128
+985% +$17.2K ﹤0.01% 742
2022
Q4 		$1.77K Hold
13
– – ﹤0.01% 1214
2022
Q3 		$1K Hold
13
– – ﹤0.01% 1172
2022
Q2 		$2K Buy
13
+3
+30% +$394 ﹤0.01% 1007
2022
Q1 		$1K Sell
10
-12
-55% -$1.44K ﹤0.01% 951
2021
Q4 		$3K Hold
22
– – ﹤0.01% 887
2021
Q3 		$3K Hold
22
– – ﹤0.01% 735
2021
Q2 		$3K Hold
22
– – ﹤0.01% 676
2021
Q1 		$2K Hold
22
– – ﹤0.01% 696
2020
Q4 		$2K Sell
22
-16
-42% -$1.7K ﹤0.01% 622
2020
Q3 		$4K Buy
+38
New +$4.23K ﹤0.01% 539

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Larson Financial Group's AZN Position: Q2 2026 in Review

Larson Financial Group increased its AstraZeneca (AZN) stake by 1.5% in Q2 2026, buying an estimated $3.76K and bringing the position to 1,354 shares worth $257K. The position accounts for 0.01% of the portfolio, ranked #753.

Larson Financial Group first reported a position in AZN in Q3 2020 and has held it in 24 quarters since. The position peaked at $272K in Q4 2025. 1,498 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Larson Financial Group held 1,354 shares of AstraZeneca worth $257K as of Q2 2026.
  • Larson Financial Group bought 20 AstraZeneca shares in Q2 2026, an estimated $3.76K.
  • AstraZeneca made up 0.01% of Larson Financial Group's portfolio in Q2 2026, its #753 holding.
  • Larson Financial Group first reported a position in AstraZeneca in Q3 2020 and has held it in 24 quarters since.
  • Larson Financial Group's AstraZeneca position peaked at $272K in Q4 2025.
  • 1,498 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.